Rigrodsky & Long, P.A.:
& Long, P.A. announces that it is investigating potential legal
claims against the board of directors of Medistem Inc. ("Medistem" or
the "Company") (OTC QB: MEDS)
regarding possible breaches of fiduciary duties and other violations of
law related to the Company's entry into an agreement to be acquired by
Intrexon Corporation ("Intrexon") (NYSE: XON),
in a transaction valued at approximately $26 million.
Click here to learn more: http://www.rigrodskylong.com/investigations/medistem-inc-meds.
Under the terms of the agreement, public shareholders of Medistem will
receive $0.27 in cash and $1.08 worth of Intrexon common stock for each
share of Medistem they own.
The investigation concerns whether Medistem's board of directors failed
to adequately shop the Company and obtain the best possible value for
Medistem's shareholders before entering into an agreement with Intrexon.
If you own the common stock of Medistem and purchased your shares before
December 20, 2013, if you have information or would like to learn more
about these claims, or if you wish to discuss these matters or have any
questions concerning this announcement or your rights or interests with
respect to these matters, please contact Seth D. Rigrodsky or Gina M.
Serra at Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300,
Garden City, New York 11530, by telephone at (888) 969-4242; by e-mail
to email@example.com, or at: http://www.rigrodskylong.com/investigations/medistem-inc-meds.
& Long, P.A., with offices in Wilmington, Delaware and Garden
City, New York, regularly prosecutes securities
class, derivative and direct actions, shareholder rights litigation and
corporate governance litigation, on behalf of shareholders in states
and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar outcome.
[ Back To NFVZone's Homepage ]